Creative Medical Technology Holdings, Inc. (CELZ) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by Creative Medical Technology Holdings, Inc. on December 19, 2022. The meeting addressed the election of directors, executive compensation matters, and the ratification of independent auditors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A quorum was established with 7,855,934 shares (55.8% of outstanding common stock) present. The following proposals were approved:
- Proposal I (Election of Directors): All five nominees (Timothy Warbington, Donald Dickerson, Michael H. Finger, Susan Snow, and Bruce S. Urdang) were elected.
- Proposal II (Executive Compensation Approval): Approved with 2,422,079 votes For, 588,661 Against, and 26,908 Abstentions.
- Proposal III (Frequency of Advisory Vote on Compensation): Stockholders voted to hold the advisory vote on an annual basis (One Year) with 2,854,354 votes.
- Proposal IV (Ratification of Auditors): The appointment of Haynie & Company as independent registered public accountants was ratified with 7,690,484 votes For.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the standard disclosure of the meeting results.
Key Facts for Investor Verification
- Verify the full composition of the newly elected Board of Directors.
- Confirm the specific terms of the executive compensation package approved in Proposal II.
- Review the definitive Proxy Statement filed on October 26, 2022, for detailed background on the proposals.
- Note that Haynie & Company has been ratified as the independent auditor.